Tamoxifen downregulates signal transduction and is synergistic with tiazofurin in human breast carcinoma MDA-MB-435 cells

Oncology Research

Volumn 10, Issue 6, 1998, Pages 325-331

  Shen, Fei ^a   Weber, George ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IP3 concentration; MDA MB 435 cells; Signal transduction; Tamoxifen; Tiazofurin

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; INOSITOL 1,4,5 TRISPHOSPHATE; RIBAVIRIN; TAMOXIFEN; TIAZOFURIN;

ARTICLE; BREAST TUMOR; CELL CULTURE; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; IC 50; METABOLISM; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DOWN-REGULATION; DRUG SYNERGISM; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; INOSITOL 1,4,5-TRISPHOSPHATE; RIBAVIRIN; SIGNAL TRANSDUCTION; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0032239513     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tormey, D. C.; Simon, R. M.; Lippman, M. E.; Bull, J. M.; Myers, C. E. Evaluation of tamoxifen dose in advanced breast cancer: A progress report. Cancer Treat. Rep. 60:1451-1459; 1976.
2. Guthrie, N.; Gapor, A.; Chambers, A. F.; Carroll, K. K. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 127:544s-548s; 1997.
3. Charlier, C.; Chariot, A.; Antoine, N.; Merville, M.; Gielen, J.; Castronovo, V. Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem. Pharmacol. 49:351-358; 1995.
4. Murphy, L. C.; Sutherland, R. L. Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro. Endocrinology 116:1071-1078; 1985.
5. Coezy, E.; Borgna, J. L.; Rochefort, H. Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res. 42:317-323; 1982.
6. Manni, A.; Wright, C.; Buck, H. Growth factor involvement in multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res. Treat. 20:43-53; 1991.
7. Knabbe, C.; Lippman, M. E.; Wakefield, L. M.; Flanders, K. C.; Kasia, A.; Derynck, R.; Dickson, R. B. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428; 1987.
8. Kiang, D. T.; Kollander, R. E.; Thomas, T.; Kennedy, B. J. Upregulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer. Cancer Res. 49:5312-5316; 1989.
9. Friedman, Z. Y. The antitumor agent tamoxifen inhibits breakdown of polyphosphoinositides in GH4C1 cells. J. Pharmacol. Exp. Ther. 271:238-245; 1994.
10. Yang, H.; Shen, F.; Herenyiova, M.; Weber, G. Phospholipase C (EC 3.1.4.11): A malignancy linked signal transduction enzyme. Anticancer Res. 18:1399-1404; 1998.
11. Weber, G.; Shen, F.; Li, W.; Prajda, N.; Hullan, L.; Yang, H. Novel advances in the regulation of signal transduction activity. Adv. Enzyme Regul. 38:1-14; 1998.
12. Olah, E.; Natsumeda, Y.; Ikegami, T,; Kote, Z.; Horanyi, M.; Szelenyi, J.; Paulik, E.; Kremmer, T.; Hollan, S. R.; Sugar, J.; Weber, G. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells. Proc. Natl. Acad. Sci. USA 85:6533-6537; 1988.
13. Olah, E.; Kote, Z.; Natsumeda, Y.; Yamaji, Y.; Jarai, G.; Lapis, E.; Financsek, I.; Weber, G. Down-regulation of c-myc and C-Ha-ras gene expression by tiazofurin in rat hepatoma cells. Cancer Biochem. Biophys. 11:107-117; 1990.
14. Weber, G.; Shen, F.; Prajda, N.; Yang, H.; Li, W.; Yeh, A.; Csoksy, B.; Olah, E.; Look, K. Y. Regulation of the signal transduction program by drugs. Adv. Enzyme Regul. 37:35-55; 1997.
15. Jayaram, H. N.; Dion, R. L.; Glazer, R. I.; Johns, D. G.; Robins, R. K.; Srivastava, P. C.; Cooney, D. A. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-D-ribofuranosylthiazole-4-carboxamide (NSC 286193). Biochem. Pharmacol. 31:2371-2380; 1982.
16. 1 phase. Cancer Res. 43:3583-3585; 1983.
17. Weber, G.; Nagai, M.; Prajda, N.; Nakamura, H.; Szekeres, T.; Olah, E. AZT: A biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells. Cancer Commun. 3:127-132; 1991.
18. Olah, E.; Lui, M. S.; Tzeng, D. Y.; Weber, G. Phase and cell cycle specificity of pyrazofurin action. Cancer Res. 40:2869-2875; 1980.
19. Shen, F.; Weber, G. Synergistic action of quercetin and genistein in human ovarian carcinoma cells. Oncol. Res. 9:597-602; 1997.
20. Singhal, R. L.; Prajda, N.; Yeh, Y. A.; Weber, G. 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): A proliferation-and malignancy-linked signal transduction enzyme. Cancer Res. 54: 5574-5578; 1994.
21. Lowry, O. H.; Rosebrough, N. J.; Fair, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
22. Chou, T.-C.; Talalay, P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22:27-55; 1984.
23. Webb, J. L. Enzyme and metabolic inhibitors, vol. 1. New York: Academic Press; 1963:107-510.
24. Berenbaum, M. C. Criteria for analyzing interactions between biological active agents. Adv. Cancer Res. 35:269-335; 1981.
25. Weber, G.; Nagai, M.; Natsumeda, Y.; Eble, J. N.; Jayaram, H. N.; Paulik, E.; Zhen, W.; Hoffman, R.; Tricot, G. Tiazofurin down-regulates express of c-Ki-ras oncogene in a leukemic patient. Cancer Commun. 3:61-66; 1991.
26. Johnston, S. R. D.; Haynes, B. P.; Sacks, N. P. M.; McKinna, J. A.; Griggs, L. J.; Jarman, M.; Baum, M.; Smith, I. E.; Dowsett, M. Effect of oestrogen receptor status and time on the intra-tumoral accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer. Breast Cancer Res. Treat. 28:241-250; 1993.
27. Rana, R. S.; Hokin, L. E. Role of phosphoinositides in transmembrane signaling. Physiol. Rev. 70:115-164; 1990.
28. Berridge, M. J. Inositol trisphosphate and calcium signalling. Nature 361:315-325; 1993.
29. Kuno, M.; Gardner, P. Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature 326:301-304; 1987.
30. Kohn, E. C.; Jacobs, W.; Kim, Y. S.; Alessandro, R.; Stetler-Stevenson, W. G.; Liotta, L. A. Calcium influx modulates expression of matrix metalloproteinase-2 (72kDa type IV collagenase, gelatinase A). J. Biol. Chem. 269:21505-21511; 1994.
31. Weber, G.; Shen, F.; Prajda, N.; Yeh, Y. A.; Yang, H.; Herenyiova, M.; Look, K. Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Res. 16:3271-3282; 1996.
32. Weber, G. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res. 43:3466-3492; 1983.
33. Tricot, G.; Weber, G. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with tiazofurin, a selective blocker of inosine 5′-monophosphate dehydrogenase (IMPDH) activity. Anticancer Res. 16:3341-3348; 1996.